GeneDx Holdings Corp.WGSNASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank67
3Y CAGR+178.2%
5Y CAGR-6.5%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+178.2%/yr
Annual compound
5Y CAGR
-6.5%/yr
Recent acceleration
Percentile
P67
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 8.18 | +20.9% |
| 2024 | 6.77 | +1950.1% |
| 2023 | 0.33 | -13.1% |
| 2022 | 0.38 | -83.3% |
| 2021 | 2.27 | -80.1% |
| 2020 | 11.43 | +23.2% |
| 2019 | 9.28 | - |